FindTrial
Sign In

retrospective study of patients with an auto-immune mediated inflammation of the eye, over last 5 years.

Clinical analysis of patients with HLA-B27 associated acute anterior uveitis: 5 - year data.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2015/12/006447
Enrollment
207
Registered
2015-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- HLA-B27 associated acute anterior Uveitis

Interventions

Control Intervention1: nil: nil

Sponsors

NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with a clinical diagnosis of unilateral or bilateral uveitis. 2. Patients with Positive HLA-B27 typing.

Exclusion criteria

Exclusion criteria: 1. Uveitis of infectious etiology.

Design outcomes

Primary

MeasureTime frame
To establish the prevalence of HLA-B27 positive uveitis in a tertiary eye hospital in Urban Bangalore and to study the clinical profile.Timepoint: To establish the prevalence of HLA-B27 positive uveitis in a tertiary eye hospital in Urban Bangalore and to study the clinical profile.—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactNamita C Anagol

NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL.

namita589@yahoo.co.in9845370131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026